Global Trends in Cancer Vaccine Clinical Trials: A 10-Year Retrospective, 2007–2016

Global Trends in Cancer Vaccine Clinical Trials: A 10-Year Retrospective, 2007–2016

10:07, July 24 2017

By GlobalData

Rhoda Awe, MSc, Clinical Trials Analyst, GlobalData, examines key drivers in the cancer vaccine clinical trial space

This white paper provides a review of global clinical trials for cancer vaccines initiated between 2007 and 2016. The data for this review were derived from the Clinical Trials Database of GlobalData's Pharma Intelligence Center. The aim of this paper is to provide analyses of the data landscape of these trials, with additional analyses on the region with the most trials initiated over the 10-year period.

Summary of Contents

3 - Introduction
3 - Report Scope
3 - Methodology
3 - Organizations Mentioned
4 - Cancer Vaccine Trial Landscape
4 - Introduction
4 - Clinical Trials by Phase and Sponsor Type
6 - Single-Country and Multinational Cancer Vaccine Trials
7 - Average Size of Cancer Vaccine Clinical Trials
8 - Top Indications for Cancer Vaccine Clinical Trials
10 - Cancer Vaccine Clinical Trials by Status
10 - Top Sponsors for Cancer Vaccine Clinical Trials
12 - Top Drugs Investigated in Cancer Vaccine Clinical Trials
13 - Cancer Vaccine Clinical Trials by Region
14 - Summary
15 - About the Authors
15 - Analyst, Clinical Trials Database
15 - Global Director of Databases and Analytics
16 - About the Pharmaceutical Clinical Trials Team
16 - About GlobalData
16 - Contact Us

Download Whitepaper

Global Trends in Cancer Vaccine Clinical Trials: A 10-Year Retrospective, 2007–2016
More Whitepapers